OV and its spin-out 2X Oncology are represented at Biotech Showcase in San Francisco
Hørsholm, Denmark, 11th of January 2018 – Oncology Venture Sweden AB (OV:ST) reports from Biotech Showcase meeting in San Francisco. Oncology Venture Sweden AB and its spinout 2X Oncology Inc. have scheduled 1:1 meetings with more than 40 companies all together. These companies are potential investors or biotech/pharma with interest in either in-licensing or co-development of oncology drugs or companies with drugs of interest to Oncology Venture for in-licensing.För ytterligare information, vänligen kontakta: Ulla Hald Buhl, COO och chef för IR & kommunikation